Zechang Lu

A novel biomarker combination of adenosine deaminase and total bile acids for predicting 3-year coronary artery disease risk in middle-aged and older hospitalized patients

Coronary artery disease (CAD) onset is a leading cause of mortality and morbidity. Short-term risk assessment, which generates greater urgency than long-term estimates, can prompt immediate preventive actions. However, validated biomarkers and tools for near-term prediction are s...